187 related articles for article (PubMed ID: 32648528)
1. Patients With Fibrotic Interstitial Lung Disease Receive Supportive and Palliative Care Just Prior to Death.
Smallwood N; Mann J; Guo H; Goh N
Am J Hosp Palliat Care; 2021 Feb; 38(2):154-160. PubMed ID: 32648528
[TBL] [Abstract][Full Text] [Related]
2. A Palliative Approach is Adopted for Many Patients Dying in Hospital with Chronic Obstructive Pulmonary Disease.
Smallwood N; Ross L; Taverner J; John J; Baisch A; Irving L; Philip J
COPD; 2018 Oct; 15(5):503-511. PubMed ID: 30822239
[TBL] [Abstract][Full Text] [Related]
3. Impact of Palliative Care in End-of-Life of Fibrotic Interstitial Lung Disease Patients.
Chai GT; Neo HY; Abisheganaden J; Hum AYM
Am J Hosp Palliat Care; 2022 Dec; 39(12):1443-1451. PubMed ID: 35389277
[No Abstract] [Full Text] [Related]
4. Development of tools to facilitate palliative and supportive care referral for patients with idiopathic pulmonary fibrosis.
Sharp C; Lamb H; Jordan N; Edwards A; Gunary R; Meek P; Millar AB; Kendall C; Adamali H
BMJ Support Palliat Care; 2018 Sep; 8(3):340-346. PubMed ID: 28667087
[TBL] [Abstract][Full Text] [Related]
5. Referral to Palliative Care Infrequent in Patients with Idiopathic Pulmonary Fibrosis Admitted to an Intensive Care Unit.
Liang Z; Hoffman LA; Nouraie M; Kass DJ; Donahoe MP; Gibson KF; Saul MI; Lindell KO
J Palliat Med; 2017 Feb; 20(2):134-140. PubMed ID: 27754815
[TBL] [Abstract][Full Text] [Related]
6. End-of-life care in oxygen-dependent ILD compared with lung cancer: a national population-based study.
Ahmadi Z; Wysham NG; Lundström S; Janson C; Currow DC; Ekström M
Thorax; 2016 Jun; 71(6):510-6. PubMed ID: 26865603
[TBL] [Abstract][Full Text] [Related]
7. Investigation burden for patients with fibrotic interstitial lung disease at the end of life.
Guo H; Mann J; Goh N; Smallwood N
Intern Med J; 2020 Jun; 50(6):748-752. PubMed ID: 32537928
[TBL] [Abstract][Full Text] [Related]
8. Assisting People With Their Living, Not Their Dying: Health Professionals' Perspectives of Palliative Care and Opioids in ILD.
Russo L; Willis K; Smallwood N
Am J Hosp Palliat Care; 2022 Feb; 39(2):211-219. PubMed ID: 34056929
[TBL] [Abstract][Full Text] [Related]
9. Early Integrated Palliative Care Bundle Impacts Location of Death in Interstitial Lung Disease: A Pilot Retrospective Study.
Archibald N; Bakal JA; Richman-Eisenstat J; Kalluri M
Am J Hosp Palliat Care; 2021 Feb; 38(2):104-113. PubMed ID: 32431183
[TBL] [Abstract][Full Text] [Related]
10. Better Together: A Mixed-Methods Study of Palliative Care Co-Management for Patients with Interstitial Lung Disease.
Bischoff KE; Choi S; Su A; Cohen E; O'Riordan DL; Oettel E; Blachman M; Meister S; Zapata C; Lindenfeld P; Calton B; Witt L; Pantilat SZ; Shah RJ
J Palliat Med; 2021 Dec; 24(12):1823-1832. PubMed ID: 34115958
[No Abstract] [Full Text] [Related]
11. Specialist palliative care is more than drugs: a retrospective study of ILD patients.
Bajwah S; Higginson IJ; Ross JR; Wells AU; Birring SS; Patel A; Riley J
Lung; 2012 Apr; 190(2):215-20. PubMed ID: 22218887
[TBL] [Abstract][Full Text] [Related]
12. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
Feng H; Zhao Y; Li Z; Kang J
Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
[TBL] [Abstract][Full Text] [Related]
13. Patients With Fibrotic Interstitial Lung Disease Hospitalized for Acute Respiratory Worsening: A Large Cohort Analysis.
Moua T; Westerly BD; Dulohery MM; Daniels CE; Ryu JH; Lim KG
Chest; 2016 May; 149(5):1205-14. PubMed ID: 26836940
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 end-of-life care: symptoms and supportive therapy use in an Australian hospital.
Wong AK; Demediuk L; Tay JY; Wawryk O; Collins A; Everitt R; Philip J; Buising K; Le B
Intern Med J; 2021 Sep; 51(9):1420-1425. PubMed ID: 33755283
[TBL] [Abstract][Full Text] [Related]
16. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
Lamb YN
Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
[TBL] [Abstract][Full Text] [Related]
17. Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Two Italian Referral Centers.
Faverio P; Piluso M; De Giacomi F; Della Zoppa M; Cassandro R; Harari S; Luppi F; Pesci A
Respiration; 2020; 99(10):838-845. PubMed ID: 33264777
[TBL] [Abstract][Full Text] [Related]
18. Benefits, for patients with late stage chronic obstructive pulmonary disease, of being cared for in specialized palliative care compared to hospital. A nationwide register study.
Henoch I; Ekberg-Jansson A; Löfdahl CG; Strang P
BMC Palliat Care; 2021 Aug; 20(1):130. PubMed ID: 34429078
[TBL] [Abstract][Full Text] [Related]
19. Palliative care and COVID-19 in the Australian context: a review of patients with COVID-19 referred to palliative care.
Mendis R; Haines A; Williams L; Mitchener K; Grimaldi F; Phillips M; Shaw M; Nguyen TPH; Dabscheck A; Spruijt O; Coperchini M
Aust Health Rev; 2021 Dec; 45(6):667-674. PubMed ID: 34446150
[TBL] [Abstract][Full Text] [Related]
20. Health Care Costs at the End of Life for Patients with Idiopathic Pulmonary Fibrosis. Evaluation of a Pilot Multidisciplinary Collaborative Interstitial Lung Disease Clinic.
Kalluri M; Lu-Song J; Younus S; Nabipoor M; Richman-Eisenstat J; Ohinmaa A; Bakal JA
Ann Am Thorac Soc; 2020 Jun; 17(6):706-713. PubMed ID: 32197048
[No Abstract] [Full Text] [Related]
[Next] [New Search]
